Premium
Letter: should we delay surgery, or stop anti‐TNF therapy prior to elective surgical procedures in Crohn’s disease patients receiving anti‐TNF agents? Authors’ reply
Author(s) -
Lin YangSheng,
Chen MingJen,
Lin WeiChen,
Wang YuanHung,
Chen Chiehfeng
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15487
Subject(s) - medicine , crohn's disease , surgery , tumor necrosis factor alpha , disease , crohn disease